XXXX in a pediatric intensive care unit.

@entity1 @entity796 @entity794 @entity281 @entity1729 @entity580 @entity2259 @entity912
In a prospective 30-month study of @entity580 in a pediatric ICU (PICU), the incidence, sites, and causes of @entity281 were determined. Factors associated with increased risk of @entity281 were investigated. In 1,388 @entity1 who remained in the PICU for a minimum of 72 h, 116 @entity281 occurred (6.1 @entity281 /100 admissions). Primary @entity2259 comprised 38% of PICU @entity281 and lower @entity1729 comprised 15%. The remaining @entity281 were divided equally among GI, skin, eye, upper respiratory, postoperative wounds, and other sites. Coagulase-negative staphylococci, @entity796 , and @entity794 were the most prevalent pathogens. Surgical @entity1 had similar rates of @entity281 to medical @entity1 . @entity1 in the first 2 yr of life, particularly those between 7 and 30 days of age, had the highest rate of @entity281 . Onset of @entity281 was more common after the first week in the PICU with 11% of @entity1 staying 14 to 20 days, 27% of @entity1 staying 21 to 27 days, 48% of @entity1 staying 28 to 34 days, and 52% of @entity1 staying more than 35 days before the onset of @entity281 . The risk of @entity580 increases with arterial and central line use, prolonged intubation, ventilation, intracranial pressure monitoring, and @entity912 .
